Nuveen Asset Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.28M | Sell |
266,404
-10,010
| -4% | -$236K | ﹤0.01% | 1878 |
|
|
2024
Q3 | $9.93M | Sell |
276,414
-357,222
| -56% | -$12.8M | ﹤0.01% | 1613 |
|
|
2024
Q2 | $22.4M | Buy |
633,636
+98,875
| +18% | +$3.49M | 0.01% | 1059 |
|
|
2024
Q1 | $15.2M | Buy |
534,761
+384,432
| +256% | +$10.9M | ﹤0.01% | 1341 |
|
|
2023
Q4 | $2M | Buy |
150,329
+2,453
| +2% | +$32.6K | ﹤0.01% | 2413 |
|
|
2023
Q3 | $1.32M | Sell |
147,876
-1,097
| -0.7% | -$9.83K | ﹤0.01% | 2460 |
|
|
2023
Q2 | $1.68M | Buy |
148,973
+14,360
| +11% | +$162K | ﹤0.01% | 2420 |
|
|
2023
Q1 | $1.55M | Sell |
134,613
-11,168
| -8% | -$129K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $1.69M | Sell |
145,781
-15,885
| -10% | -$184K | ﹤0.01% | 2467 |
|
|
2022
Q3 | $2.05M | Sell |
161,666
-39,022
| -19% | -$496K | ﹤0.01% | 2391 |
|
|
2022
Q2 | $1.38M | Buy |
200,688
+57,863
| +41% | +$398K | ﹤0.01% | 2629 |
|
|
2022
Q1 | $1.28M | Buy |
142,825
+2,882
| +2% | +$25.9K | ﹤0.01% | 2706 |
|
|
2021
Q4 | $1.66M | Sell |
139,943
-5,835
| -4% | -$69.4K | ﹤0.01% | 2655 |
|
|
2021
Q3 | $2.37M | Sell |
145,778
-5,953
| -4% | -$96.7K | ﹤0.01% | 2592 |
|
|
2021
Q2 | $3.19M | Buy |
151,731
+110,223
| +266% | +$2.32M | ﹤0.01% | 2484 |
|
|
2021
Q1 | $644K | Buy |
41,508
+18,190
| +78% | +$282K | ﹤0.01% | 3033 |
|
|
2020
Q4 | $490K | Buy |
+23,318
| New | +$490K | ﹤0.01% | 3047 |
|